跳至主要内容
临床试验/IRCT201104245625N2
IRCT201104245625N2已完成2 期

Comparative efficacy and complications of Two–Hour versus 24-Hour Regimen of Streptokinase in Acute Pulmonary Embolism In Tehran Heart Center

Vice Chancellor for research,Tehran Heart Center (TUMS)0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • streptokinase only begin for massive or submassive pulmonary emboli patients who have these conditions:
  • unstable hemodynamic (systolic blood pressure less than 90 mmHg or reduce systolic blood pressure more 40 mmhg)
  • intermediate or sever RV dysfunction(right ventricle)
  • Exclusion criteria:
  • history of hemorrhagic stroke or unknown origin stroke;Ischemic stroke in past 6 months;central nervous system neoplasm;
  • major trauma,head surgery or injury in past 3 months;TIA attack in past 6 months;oral anticoagulant drugs users;pregnancy or 1st post partum week;traumatic resuscitation;resistant hypertension(systolic blood pressure more than180 mmHg);progressive liver disease;infected endocarditis;active stomach ulcer;

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research,Tehran Heart Center (TUMS)

相似试验

streptokinase in acute pulmonary embolism | 临床试验